Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
Using human sera having antibodies against Epstein-Barr virus (EBV) early antigens (EA)  but lacking antibodies directed against the EB nuclear antigen (EBNA), the detection of EBV/EA was possible both by the anticomplement immunofluorescent test (ACIF) and by the classical complement fixation test (CF). The latter is particularly suitable for biochemical studies on EA.
D000914:Antibodies, Viral; D000917:Antibody Formation; D000956:Antigens, Viral / Q000302:isolation & purification*; D002460:Cell Line; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000276:immunology*; D008722:Methods
D000914:Antibodies, Viral; D000956:Antigens, Viral